Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Malignancy in Giant Cell Tumor of Bone: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,433 of 28,963 conditions by registered trial count.

Browse conditions → How counts are built

1 US clinical trials · none currently recruiting · #11,433 of 28,963 conditions by registered trial count

Malignancy in Giant Cell Tumor of Bone: 1 US clinical trial tracked, none currently recruiting.

Malignancy in Giant Cell Tumor of Bone is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition malignancy-in-giant-cell-tumor-of-bone

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11433 | SPON 1

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Malignancy in Giant Cell (th…0%
Open-enrollment share among volume-matched conditions near Malignancy in Giant Cell Tumor of Bone

Malignancy in Giant Cell Tumor of Bone has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Malignancy in Giant Cell Tumor of Bone on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Malignancy in Giant Cell Tumor of Bone is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 28,061 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

M.D. Anderson Cancer Center 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Compare conditions side-by-side

Read our methodology - how this data is sourced, computed, and verified.

Research context

Helpful clinical-trial guides

This page summarizes registry records, not medical advice or a recommendation to join a study. These guides explain how to interpret the information shown here and what to verify with a study team.

How clinical trials workUnderstand study records, eligibility, and study status. Finding a trialLearn the questions to take to a study contact or clinician. Informed consentReview what consent does and does not mean for participants.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.